Homologous and Heterologous Regulation of Somatostatin Receptor 2

We previously demonstrated that phosphorylation of somatostatin receptor 2A (sst2A) is rapidly increased in transfected cells both by agonist and by the protein kinase C (PKC) activator phorbol myristate acetate (PMA). Here, we investigate whether PKC-mediated receptor phosphorylation is involved in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular endocrinology (Baltimore, Md.) Md.), 2002-11, Vol.16 (11), p.2502-2514
Hauptverfasser: Elberg, Gerard, Hipkin, R. William, Schonbrunn, Agnes
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2514
container_issue 11
container_start_page 2502
container_title Molecular endocrinology (Baltimore, Md.)
container_volume 16
creator Elberg, Gerard
Hipkin, R. William
Schonbrunn, Agnes
description We previously demonstrated that phosphorylation of somatostatin receptor 2A (sst2A) is rapidly increased in transfected cells both by agonist and by the protein kinase C (PKC) activator phorbol myristate acetate (PMA). Here, we investigate whether PKC-mediated receptor phosphorylation is involved in the homologous or heterologous regulation of endogenous sst2 receptors in AR42J pancreatic acinar cells upon stimulation by agonist or by cholecystokinin (CCK) or bombesin (BBS). Somatostatin, PMA, CCK, and BBS all increased sst2A receptor phosphorylation 5- to 10-fold within minutes. Somatostatin binding also caused rapid internalization of the ligand-receptor complex, and PMA, CCK, and BBS all stimulated this internalization further. Additionally, sst2 receptor-mediated inhibition of adenylyl cyclase was desensitized by all treatments. Somatostatin, as well as peptidic (SMS201–995) and nonpeptidic (L-779,976) sst2 receptor agonists increased the EC50 for somatostatin inhibition 20-fold. In contrast, pretreatment with BBS, CCK, or PMA caused a modest 2-fold increase in the EC50 for cyclase inhibition. Whereas the PKC inhibitor GF109203X abolished sst2A receptor phosphorylation by CCK, BBS, and PMA, it did not alter the effect of somatostatin, demonstrating that these reactions were catalyzed by different kinases. Consistent with a functional role for PKC-mediated receptor phosphorylation, GF109203X prevented PMA stimulation of sst2 receptor internalization. Surprisingly, however, GF109203X did not inhibit BBS and CCK stimulation of sst2A receptor endocytosis. These results demonstrate that homologous and heterologous hormones induce sst2A receptor phosphorylation by PKC-independent and -dependent mechanisms, respectively, and produce distinct effects on receptor signaling and internalization. In addition, the heterologous hormones also modulate sst2 receptor internalization by a novel mechanism that is independent of receptor phosphorylation.
doi_str_mv 10.1210/me.2002-0207
format Article
fullrecord <record><control><sourceid>oup_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1210_me_2002_0207</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1210/me.2002-0207</oup_id><sourcerecordid>10.1210/me.2002-0207</sourcerecordid><originalsourceid>FETCH-LOGICAL-c401t-5651e5371c744bcf74dc3108f868a554f7ecb6b7a136b112676c4a31f596921b3</originalsourceid><addsrcrecordid>eNp1kM1Lw0AUxBdRbK3ePEtuXkzdtx_ZzbGUaoWC4Md52WxeSkuTDbvJwf_elFS86OnBvB_DzBByC3QODOhjjXNGKUspo-qMTCEXIs1zUOdkSrXWqdY0n5CrGPeUgpAaLskEmKBc83xKFmtf-4Pf-j4mtimTNXYYfoQ33PYH2-18k_gqefe17XzsBqEZXg7bzoeEXZOLyh4i3pzujHw-rT6W63Tz-vyyXGxSJyh0qcwkoOQKnBKicJUSpeNAdaUzbaUUlUJXZIWywLMCgGUqc8JyqGSe5QwKPiMPo68LPsaAlWnDrrbhywA1xyVMjea4hDkuMeB3I972RY3lL3yqPgD3I-D79j-r9GTFRxKb0ruwa7ANGKPZ-z40Q-W_A3wDrVd1Zg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Homologous and Heterologous Regulation of Somatostatin Receptor 2</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Alma/SFX Local Collection</source><creator>Elberg, Gerard ; Hipkin, R. William ; Schonbrunn, Agnes</creator><creatorcontrib>Elberg, Gerard ; Hipkin, R. William ; Schonbrunn, Agnes</creatorcontrib><description>We previously demonstrated that phosphorylation of somatostatin receptor 2A (sst2A) is rapidly increased in transfected cells both by agonist and by the protein kinase C (PKC) activator phorbol myristate acetate (PMA). Here, we investigate whether PKC-mediated receptor phosphorylation is involved in the homologous or heterologous regulation of endogenous sst2 receptors in AR42J pancreatic acinar cells upon stimulation by agonist or by cholecystokinin (CCK) or bombesin (BBS). Somatostatin, PMA, CCK, and BBS all increased sst2A receptor phosphorylation 5- to 10-fold within minutes. Somatostatin binding also caused rapid internalization of the ligand-receptor complex, and PMA, CCK, and BBS all stimulated this internalization further. Additionally, sst2 receptor-mediated inhibition of adenylyl cyclase was desensitized by all treatments. Somatostatin, as well as peptidic (SMS201–995) and nonpeptidic (L-779,976) sst2 receptor agonists increased the EC50 for somatostatin inhibition 20-fold. In contrast, pretreatment with BBS, CCK, or PMA caused a modest 2-fold increase in the EC50 for cyclase inhibition. Whereas the PKC inhibitor GF109203X abolished sst2A receptor phosphorylation by CCK, BBS, and PMA, it did not alter the effect of somatostatin, demonstrating that these reactions were catalyzed by different kinases. Consistent with a functional role for PKC-mediated receptor phosphorylation, GF109203X prevented PMA stimulation of sst2 receptor internalization. Surprisingly, however, GF109203X did not inhibit BBS and CCK stimulation of sst2A receptor endocytosis. These results demonstrate that homologous and heterologous hormones induce sst2A receptor phosphorylation by PKC-independent and -dependent mechanisms, respectively, and produce distinct effects on receptor signaling and internalization. In addition, the heterologous hormones also modulate sst2 receptor internalization by a novel mechanism that is independent of receptor phosphorylation.</description><identifier>ISSN: 0888-8809</identifier><identifier>EISSN: 1944-9917</identifier><identifier>DOI: 10.1210/me.2002-0207</identifier><identifier>PMID: 12403839</identifier><language>eng</language><publisher>United States: Endocrine Society</publisher><subject>Adenylyl Cyclase Inhibitors ; Amides - pharmacology ; Animals ; Cell Line ; Indoles - pharmacology ; Octreotide - pharmacology ; Pancreas ; Phosphorylation ; Protein Kinase C - metabolism ; Rats ; Receptors, Somatostatin - drug effects ; Receptors, Somatostatin - genetics ; Receptors, Somatostatin - metabolism ; Somatostatin - pharmacology ; Tetradecanoylphorbol Acetate - pharmacology</subject><ispartof>Molecular endocrinology (Baltimore, Md.), 2002-11, Vol.16 (11), p.2502-2514</ispartof><rights>Copyright © 2002 by The Endocrine Society 2002</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c401t-5651e5371c744bcf74dc3108f868a554f7ecb6b7a136b112676c4a31f596921b3</citedby><cites>FETCH-LOGICAL-c401t-5651e5371c744bcf74dc3108f868a554f7ecb6b7a136b112676c4a31f596921b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12403839$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Elberg, Gerard</creatorcontrib><creatorcontrib>Hipkin, R. William</creatorcontrib><creatorcontrib>Schonbrunn, Agnes</creatorcontrib><title>Homologous and Heterologous Regulation of Somatostatin Receptor 2</title><title>Molecular endocrinology (Baltimore, Md.)</title><addtitle>Mol Endocrinol</addtitle><description>We previously demonstrated that phosphorylation of somatostatin receptor 2A (sst2A) is rapidly increased in transfected cells both by agonist and by the protein kinase C (PKC) activator phorbol myristate acetate (PMA). Here, we investigate whether PKC-mediated receptor phosphorylation is involved in the homologous or heterologous regulation of endogenous sst2 receptors in AR42J pancreatic acinar cells upon stimulation by agonist or by cholecystokinin (CCK) or bombesin (BBS). Somatostatin, PMA, CCK, and BBS all increased sst2A receptor phosphorylation 5- to 10-fold within minutes. Somatostatin binding also caused rapid internalization of the ligand-receptor complex, and PMA, CCK, and BBS all stimulated this internalization further. Additionally, sst2 receptor-mediated inhibition of adenylyl cyclase was desensitized by all treatments. Somatostatin, as well as peptidic (SMS201–995) and nonpeptidic (L-779,976) sst2 receptor agonists increased the EC50 for somatostatin inhibition 20-fold. In contrast, pretreatment with BBS, CCK, or PMA caused a modest 2-fold increase in the EC50 for cyclase inhibition. Whereas the PKC inhibitor GF109203X abolished sst2A receptor phosphorylation by CCK, BBS, and PMA, it did not alter the effect of somatostatin, demonstrating that these reactions were catalyzed by different kinases. Consistent with a functional role for PKC-mediated receptor phosphorylation, GF109203X prevented PMA stimulation of sst2 receptor internalization. Surprisingly, however, GF109203X did not inhibit BBS and CCK stimulation of sst2A receptor endocytosis. These results demonstrate that homologous and heterologous hormones induce sst2A receptor phosphorylation by PKC-independent and -dependent mechanisms, respectively, and produce distinct effects on receptor signaling and internalization. In addition, the heterologous hormones also modulate sst2 receptor internalization by a novel mechanism that is independent of receptor phosphorylation.</description><subject>Adenylyl Cyclase Inhibitors</subject><subject>Amides - pharmacology</subject><subject>Animals</subject><subject>Cell Line</subject><subject>Indoles - pharmacology</subject><subject>Octreotide - pharmacology</subject><subject>Pancreas</subject><subject>Phosphorylation</subject><subject>Protein Kinase C - metabolism</subject><subject>Rats</subject><subject>Receptors, Somatostatin - drug effects</subject><subject>Receptors, Somatostatin - genetics</subject><subject>Receptors, Somatostatin - metabolism</subject><subject>Somatostatin - pharmacology</subject><subject>Tetradecanoylphorbol Acetate - pharmacology</subject><issn>0888-8809</issn><issn>1944-9917</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kM1Lw0AUxBdRbK3ePEtuXkzdtx_ZzbGUaoWC4Md52WxeSkuTDbvJwf_elFS86OnBvB_DzBByC3QODOhjjXNGKUspo-qMTCEXIs1zUOdkSrXWqdY0n5CrGPeUgpAaLskEmKBc83xKFmtf-4Pf-j4mtimTNXYYfoQ33PYH2-18k_gqefe17XzsBqEZXg7bzoeEXZOLyh4i3pzujHw-rT6W63Tz-vyyXGxSJyh0qcwkoOQKnBKicJUSpeNAdaUzbaUUlUJXZIWywLMCgGUqc8JyqGSe5QwKPiMPo68LPsaAlWnDrrbhywA1xyVMjea4hDkuMeB3I972RY3lL3yqPgD3I-D79j-r9GTFRxKb0ruwa7ANGKPZ-z40Q-W_A3wDrVd1Zg</recordid><startdate>200211</startdate><enddate>200211</enddate><creator>Elberg, Gerard</creator><creator>Hipkin, R. William</creator><creator>Schonbrunn, Agnes</creator><general>Endocrine Society</general><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>200211</creationdate><title>Homologous and Heterologous Regulation of Somatostatin Receptor 2</title><author>Elberg, Gerard ; Hipkin, R. William ; Schonbrunn, Agnes</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c401t-5651e5371c744bcf74dc3108f868a554f7ecb6b7a136b112676c4a31f596921b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adenylyl Cyclase Inhibitors</topic><topic>Amides - pharmacology</topic><topic>Animals</topic><topic>Cell Line</topic><topic>Indoles - pharmacology</topic><topic>Octreotide - pharmacology</topic><topic>Pancreas</topic><topic>Phosphorylation</topic><topic>Protein Kinase C - metabolism</topic><topic>Rats</topic><topic>Receptors, Somatostatin - drug effects</topic><topic>Receptors, Somatostatin - genetics</topic><topic>Receptors, Somatostatin - metabolism</topic><topic>Somatostatin - pharmacology</topic><topic>Tetradecanoylphorbol Acetate - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Elberg, Gerard</creatorcontrib><creatorcontrib>Hipkin, R. William</creatorcontrib><creatorcontrib>Schonbrunn, Agnes</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Molecular endocrinology (Baltimore, Md.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Elberg, Gerard</au><au>Hipkin, R. William</au><au>Schonbrunn, Agnes</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Homologous and Heterologous Regulation of Somatostatin Receptor 2</atitle><jtitle>Molecular endocrinology (Baltimore, Md.)</jtitle><addtitle>Mol Endocrinol</addtitle><date>2002-11</date><risdate>2002</risdate><volume>16</volume><issue>11</issue><spage>2502</spage><epage>2514</epage><pages>2502-2514</pages><issn>0888-8809</issn><eissn>1944-9917</eissn><abstract>We previously demonstrated that phosphorylation of somatostatin receptor 2A (sst2A) is rapidly increased in transfected cells both by agonist and by the protein kinase C (PKC) activator phorbol myristate acetate (PMA). Here, we investigate whether PKC-mediated receptor phosphorylation is involved in the homologous or heterologous regulation of endogenous sst2 receptors in AR42J pancreatic acinar cells upon stimulation by agonist or by cholecystokinin (CCK) or bombesin (BBS). Somatostatin, PMA, CCK, and BBS all increased sst2A receptor phosphorylation 5- to 10-fold within minutes. Somatostatin binding also caused rapid internalization of the ligand-receptor complex, and PMA, CCK, and BBS all stimulated this internalization further. Additionally, sst2 receptor-mediated inhibition of adenylyl cyclase was desensitized by all treatments. Somatostatin, as well as peptidic (SMS201–995) and nonpeptidic (L-779,976) sst2 receptor agonists increased the EC50 for somatostatin inhibition 20-fold. In contrast, pretreatment with BBS, CCK, or PMA caused a modest 2-fold increase in the EC50 for cyclase inhibition. Whereas the PKC inhibitor GF109203X abolished sst2A receptor phosphorylation by CCK, BBS, and PMA, it did not alter the effect of somatostatin, demonstrating that these reactions were catalyzed by different kinases. Consistent with a functional role for PKC-mediated receptor phosphorylation, GF109203X prevented PMA stimulation of sst2 receptor internalization. Surprisingly, however, GF109203X did not inhibit BBS and CCK stimulation of sst2A receptor endocytosis. These results demonstrate that homologous and heterologous hormones induce sst2A receptor phosphorylation by PKC-independent and -dependent mechanisms, respectively, and produce distinct effects on receptor signaling and internalization. In addition, the heterologous hormones also modulate sst2 receptor internalization by a novel mechanism that is independent of receptor phosphorylation.</abstract><cop>United States</cop><pub>Endocrine Society</pub><pmid>12403839</pmid><doi>10.1210/me.2002-0207</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0888-8809
ispartof Molecular endocrinology (Baltimore, Md.), 2002-11, Vol.16 (11), p.2502-2514
issn 0888-8809
1944-9917
language eng
recordid cdi_crossref_primary_10_1210_me_2002_0207
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Oxford University Press Journals All Titles (1996-Current); Alma/SFX Local Collection
subjects Adenylyl Cyclase Inhibitors
Amides - pharmacology
Animals
Cell Line
Indoles - pharmacology
Octreotide - pharmacology
Pancreas
Phosphorylation
Protein Kinase C - metabolism
Rats
Receptors, Somatostatin - drug effects
Receptors, Somatostatin - genetics
Receptors, Somatostatin - metabolism
Somatostatin - pharmacology
Tetradecanoylphorbol Acetate - pharmacology
title Homologous and Heterologous Regulation of Somatostatin Receptor 2
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T21%3A07%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Homologous%20and%20Heterologous%20Regulation%20of%20Somatostatin%20Receptor%202&rft.jtitle=Molecular%20endocrinology%20(Baltimore,%20Md.)&rft.au=Elberg,%20Gerard&rft.date=2002-11&rft.volume=16&rft.issue=11&rft.spage=2502&rft.epage=2514&rft.pages=2502-2514&rft.issn=0888-8809&rft.eissn=1944-9917&rft_id=info:doi/10.1210/me.2002-0207&rft_dat=%3Coup_cross%3E10.1210/me.2002-0207%3C/oup_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/12403839&rft_oup_id=10.1210/me.2002-0207&rfr_iscdi=true